A 15‐years follow‐up of deferasirox in beta‐thalassaemia major patients with iron overload

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-11, Vol.191 (3), p.e81-e83
Hauptverfasser:	Wei, Zhenbin, Yang, Gaohui, Huang, Yumei, Peng, Peng, Long, Liling, Long, Yuan, Huang, Xiaoping, Zhou, Xuemei, Lai, Yongrong, Liu, Rongrong
Format:	Artikel
Sprache:	eng
Schlagworte:	beta-Thalassemia - complications Biomarkers Blood diseases deferasirox Deferasirox - administration & dosage Deferasirox - adverse effects Deferasirox - therapeutic use Follow-Up Studies Hematology Humans Iron Chelating Agents - administration & dosage Iron Chelating Agents - adverse effects Iron Chelating Agents - therapeutic use iron chelation therapy iron overload Iron Overload - complications Iron Overload - diagnosis Iron Overload - drug therapy Iron Overload - etiology long‐term follow‐up Prognosis Thalassemia Treatment Outcome β thalassemia major
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!